Effectiveness and Cost-Benefit of Influenza Vaccination of Healthy Working Adults

2000659 citationsJournal Article

Authors

Carolyn B. Bridges · Centers for Disease Control and Prevention

W. Thompson · National Center for Infectious Diseases

Martin I. Meltzer · National Center for Infectious Diseases

Gordon R. Reeve · National Center for Infectious Diseases

Walter J. Talamonti · Centers for Disease Control and Prevention

Nancy J. Cox · Centers for Disease Control and Prevention

Heather A. Lilac

Abstract

Influenza vaccination of healthy working adults younger than 65 years can reduce the rates of ILI, lost workdays, and physician visits during years when the vaccine and circulating viruses are similar, but vaccination may not provide overall economic benefits in most years. JAMA. 2000;284:1655-1663.

Topics & Keywords

Influenza Virus Research Studies Respiratory viral infections research Animal Disease Management and Epidemiology

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JAMA

Volume 284, Issue 13, pp. 1655-1655

DOI: 10.1001/jama.284.13.1655

Field-Weighted Citation Impact: 19.56